Record · corpus.blog/posts/01a0f576-b8a4-72cc-b1d6-42a56b89abef
Beamion PANTUMOR-1: A phase II, multicenter, multicohort, open-label trial to evaluate the efficacy and safety of the oral HER2-selective tyrosine kinase inhibitor zongertinib for the treatment of <em>HER2</em>-mutated or overexpressed/amplified solid tumors.
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs · published 30 September 2026 · 2 min read
A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.
0blogs citing
- First cited
- —
- Most recent
- —
- Rank this month
- not ranked
- External links
- 0
- Words captured
- 309
Cited by
No blog we hold has cited this post yet.
Similar posts
HER2-Low Breast Cancer Treatment
verywellhealth.com
12 Sept 2026
The Most Effective HER2-Positive Breast Cancer Treatments
verywellhealth.com
20 Sept 2026
Links from this post
This post doesn't link to any pages we've captured.
Something wrong here? Report a problem
A post on inventcures.github.io, published 30 September 2026, has not been cited by any blog yet (corpus.blog, measured 8 October 2026).